Dr Niven Mehra is Consultant in Medical Oncology at the Radboud University, Nijmegen, The Netherlands.
He studied Medicine at the University Medical Center Utrecht where he graduated in 2002. He completed a PhD in translational research in 2006 (under Emile Voest), followed by training in Internal Medicine from 2006 to 2011 and in Medical Oncology from 2011 to 2014.
In 2014 he focused on urogenital oncology during a Clinical Research Fellowship at the Royal Marsden NHS Trust and the Institute of Cancer Research (under Johann de Bono) where he was a sub-investigator for clinical trials in the Prostate Targeted Therapy Group. His post-doctorate research at the Institute of Cancer Research is focused on biomarkers discovery in liquid biopsies using next-generation sequencing techniques, and on the role of immune suppressive cells driving treatment resistance in prostate cancer.
Niven Mehra is member of the Educational Publications Working Group of the European Society for Medical Oncology (ESMO), and author of several peer-reviewed research papers in international journals, cancer text- and handbooks.